Leaflet DORNITE 25mg film-coated tablets

Product code:
W65611001
Quantity:
7
Indicated for:
allergic rhinitis; urticaria
Route of administration:
oral
Substance:
doxylamine (antiallergic agent)
ATC
R06AA09 — Respiratory system | Antihistamines for systemic use | Antihistamines for systemic use | Aminoalkyl ethers

Precautions:

Driving impairment

This medicine may affect your ability to drive or use machines.

Glaucoma warning

Use caution if you have glaucoma or increased eye pressure.

Anticholinergic effects

May cause dry mouth, constipation, urinary retention, or blurred vision.

Drowsiness / sedation

This medicine may cause drowsiness or reduced alertness.

Doxylamine is an antihistamine used for the short-term treatment of insomnia and for relieving allergic symptoms such as rhinitis or urticaria. It works by blocking H1 histamine receptors, producing a sedative effect.

The medication is taken orally, usually before bedtime, as directed by a doctor or the product leaflet.

Side effects may include drowsiness, dry mouth, dizziness, or constipation. In rare cases, severe allergic reactions or confusion may occur.

Doxylamine is not recommended for patients with hypersensitivity to this medication, closed-angle glaucoma, or urinary retention.

General data about DORNITE 25mg

Substance:
doxylamine
Date of latest medicines list:
01-06-2019
Product code:
W65611001
Concentration:
25mg
Pharmaceutical form:
film-coated tablets
Quantity:
7
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
KRKA, D.D., NOVO MESTO - SLOVENIA
Holder:
KRKA, D.D., NOVO MESTO - SLOVENIA
Number:
11287/2018/01
Shelf life:
2 years